Stephen H. Willard

Stephen H. Willard is a declared insider at 2 companies; the most frequent names are Longeveron Inc. and NRX Pharmaceuticals, Inc. In total, 5 filings cover trades dated from 16 December 2022 to 1 October 2026.

No open-market sale appears; the market trades are 1 purchase worth €55k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 4 share grants.

The latest filing, published on 5 October 2026, reports a share grant of €4,540 in Longeveron Inc. The clock since the last published purchase (19 December 2022) now reads 1,399 days. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.